Teva Settles Propofol Lawsuits for $250 Million
Teva Pharmaceuticals Industries Ltd. has agreed to pay more than $250 million to settle more than 80 dangerous drug lawsuits claiming the drug manufacturer sold Propofol in a manner that led to colonoscopy patients developing hepatitis C. According to Bloomberg , the patients had alleged that Teva intentionally sold the anesthetic in large vials to encourage medical professionals to reuse them, even though doing so could